导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.20% | 1717/4773 |
| 近一周 | -3.09% | 3651/5462 |
| 近一月 | -9.62% | 4783/5421 |
| 近一季 | -18.58% | 4732/5209 |
| 近半年 | -1.71% | 1671/4920 |
| 近一年 | 6.85% | 1399/4366 |
| 近两年 | 110.64% | 472/2954 |
| 近三年 | 64.07% | 385/2253 |
| 成立以来 | 73.75% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.37% 1773/4961 |
36.11% 901/5312 |
- - |
- - |
| 2025 | 49.24% 491/4813 |
-1.38% 2651/3635 |
3.36% 1035/4076 |
46.96% 500/4524 |
-0.37% 2473/4813 |
| 2024 | 14.35% 1055/3463 |
-4.42% 1660/2808 |
-5.61% 1758/3014 |
27.45% 223/3129 |
-0.55% 1458/3463 |
| 2023 | -20.65% 1879/2656 |
- 1768/2280 |
-6.51% 1658/2385 |
-9.77% 1894/2515 |
-5.93% 1565/2655 |
| 2022 | -28.06% 1525/2207 |
-18.43% 1337/1919 |
6.07% 773/2016 |
-16.96% 1533/2113 |
0.13% 1539/2208 |
| 2021 | 8.33% 482/1822 |
-8.51% 1088/1255 |
26.23% 76/1330 |
-6.46% 934/1466 |
0.28% 1144/1822 |
| 2020 | 63.85% 103/1250 |
3.13% 126/1028 |
29.44% 75/1067 |
5.99% 881/1164 |
15.81% 189/1184 |
| 2019 | 42.17% 221/1092 |
33.11% 145/754 |
-9.53% 664/804 |
7.25% 97/850 |
10.08% 164/918 |
| 2018 | -25.52% 357/834 |
- - |
- - |
- - |
-10.74% 218/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 融通创业板指数C VS. 长安沪深300非周期A(740101) |